Portola Pharmaceuticals, Inc. Earnings Per Share, Basic and Diluted
Portola Pharmaceuticals, Inc. reported Earnings Per Share, Basic and Diluted of -$0.88 per share for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-11.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2020-05-11
- Portola Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2020-03-31 was -$0.88.
- Portola Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2019-12-31 was -$1.24.
- Portola Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2019-09-30 was -$0.68.
- Portola Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2019-06-30 was -$0.97.
- Portola Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2019 was -$4.06.
- Portola Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2018 was -$5.31.
- Portola Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2017 was -$4.81.
- Portola Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2016 was -$4.76.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2020-03-31 | -$0.88 10-Q · filed 2020-05-11 | |||
| 2019-12-31 | -$1.24 10-K · filed 2020-02-28 | -$4.06 10-K · filed 2020-02-28 | ||
| 2019-09-30 | -$0.68 10-K · filed 2020-02-28 | -$2.79 10-Q · filed 2019-11-05 | ||
| 2019-06-30 | -$0.97 10-K · filed 2020-02-28 | -$2.14 10-Q · filed 2019-08-07 | ||
| 2019-03-31 | -$1.17 10-Q · filed 2020-05-11 | |||
| 2018-12-31 | -$1.34 10-K · filed 2020-02-28 | -$5.31 10-K · filed 2020-02-28 | ||
| 2018-09-30 | -$1.08 10-K · filed 2020-02-28 | -$3.97 10-Q · filed 2019-11-05 | ||
| 2018-06-30 | -$1.61 10-K · filed 2020-02-28 | -$2.90 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | -$1.28 10-K · filed 2020-02-28 | |||
| 2017-12-31 | -$1.41 10-K · filed 2019-03-01 | -$4.81 10-K · filed 2020-02-28 | ||
| 2017-09-30 | -$1.41 10-K · filed 2019-03-01 | -$3.38 10-Q · filed 2018-11-07 | ||
| 2017-06-30 | -$1.22 10-K · filed 2019-03-01 | -$1.96 10-Q · filed 2018-08-09 | ||
| 2017-03-31 | -$0.74 10-K · filed 2019-03-01 | |||
| 2016-12-31 | -$0.95 10-K · filed 2018-03-01 | -$4.76 10-K · filed 2019-03-01 | ||
| 2016-09-30 | -$1.64 10-K · filed 2018-03-01 | -$3.81 10-Q · filed 2017-11-09 | ||
| 2016-06-30 | -$1.02 10-K · filed 2018-03-01 | -$2.17 10-Q · filed 2017-08-09 | ||
| 2016-03-31 | -$1.15 10-K · filed 2018-03-01 | |||
| 2015-12-31 | -$1.23 10-K · filed 2017-03-01 | -$4.36 10-K · filed 2018-03-01 | ||
| 2015-09-30 | -$1.05 10-K · filed 2017-03-01 | -$3.12 10-Q · filed 2016-11-07 | ||
| 2015-06-30 | -$1.12 10-K · filed 2017-03-01 | -$2.07 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | -$0.95 10-K · filed 2017-03-01 | |||
| 2014-12-31 | -$0.82 10-K · filed 2016-02-29 | -$3.19 10-K · filed 2017-03-01 | ||
| 2014-09-30 | -$0.86 10-K · filed 2016-02-29 | -$2.37 10-Q · filed 2015-11-09 | ||
| 2014-06-30 | -$0.76 10-K · filed 2016-02-29 | -$1.51 10-Q · filed 2015-08-05 | ||
| 2014-03-31 | -$0.75 10-K · filed 2016-02-29 | |||
| 2013-12-31 | -$0.63 10-K · filed 2015-03-02 | -$1.16 derived: net income ÷ weighted average shares · filed 2016-02-29 | -$2.18 derived: net income ÷ weighted average shares · filed 2016-02-29 | -$3.65 10-K · filed 2016-02-29 |
| 2013-09-30 | -$0.53 10-K · filed 2015-03-02 | -$1.61 derived: net income ÷ weighted average shares · filed 2014-11-10 | -$3.39 10-Q · filed 2014-11-10 | |
| 2013-06-30 | -$1.47 10-K · filed 2015-03-02 | -$4.92 10-Q · filed 2014-08-06 | ||
| 2013-03-31 | -$12.94 10-K · filed 2015-03-02 |